80 FR 35656 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 119 (June 22, 2015)

Page Range		35656-35656
FR Document		2015-15168

Federal Register, Volume 80 Issue 119 (Monday, June 22, 2015)

[Federal Register Volume 80, Number 119 (Monday, June 22, 2015)]
[Notices]
[Page 35656]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-15168]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Developing Technologies and Tools to Monitor HIV 
Brain Reservoirs and How They May be Altered by Exposure to 
Substances of Abuse (R21/R33).
    Date: July 16, 2015.
    Time: 1:30 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Susan O. McGuire, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., 
Room 4245, Rockville, MD 20852, 301-435-1426, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA I/START Small Grant Review.
    Date: July 21, 2015.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
    Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 4234, MSC 9550, Bethesda, MD 02892, 301-443-9511, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: June 16, 2015.
Michelle Trout,
 Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-15168 Filed 6-19-15; 8:45 am]
BILLING CODE 4140-01-P

35656 Federal Register / Vol. 80, No. 119 / Monday, June 22, 2015 / Notices

DATES: The meeting will be held on July 22, 2015. Time for public comment Extramural Affairs, National Institute on
Tuesday, July 21, 2015, from 8:30 a.m. sessions will be allotted both days. Drug Abuse, National Institutes of Health,
until 5:00 p.m. and Wednesday, July 22, Public attendance at the meeting is DHHS, 6001 Executive Blvd., Room 4245,
2015, from 8:30 a.m. until 4:30 p.m. limited to space available. Individuals Rockville, MD 20852, 301–435–1426,
who plan to attend and need special mcguireso@mail.nih.gov.
ADDRESSES: Fishers Lane Conference
assistance, such as sign language Name of Committee: National Institute on
Center, Terrace Level, 5635 Fishers Drug Abuse Special Emphasis Panel, NIDA I/
Lane, Rockville, Maryland 20852. interpretation or other reasonable
START Small Grant Review.
FOR FURTHER INFORMATION CONTACT: Jerry
accommodations, should notify one of Date: July 21, 2015.
Menikoff, M.D., J.D., Director, Office for the designated SACHRP points of Time: 12:00 p.m. to 2:00 p.m.
Human Research Protections (OHRP), or contact at the address/phone number Agenda: To review and evaluate grant
Julia Gorey, J.D., Executive Director, listed above at least one week prior to applications.
SACHRP; U.S. Department of Health the meeting. Pre-registration is required Place: National Institutes of Health,
for participation in the on-site public Neuroscience Center, 6001 Executive
and Human Services, 1101 Wootton Boulevard, Rockville, MD 20852, (Virtual
comment session; individuals may pre-
Parkway, Suite 200, Rockville, Meeting).
register the day of the meeting.
Maryland 20852; 240–453–8141; fax: Contact Person: Jagadeesh S. Rao, Ph.D.,
Individuals who would like to submit
240–453–6909; email address: Scientific Review Officer, Office of
written statements should email or fax
SACHRP@hhs.gov. Extramural Affairs, National Institute on
their comments to SACHRP at Drug Abuse, National Institutes of Health,
SUPPLEMENTARY INFORMATION: Under the SACHRP@hhs.gov at least five business
authority of 42 U.S.C. 217a, Section 222 DHHS, 6001 Executive Boulevard, Room
days prior to the meeting. 4234, MSC 9550, Bethesda, MD 02892, 301–
of the Public Health Service Act, as
Dated: June 17, 2015. 443–9511, jrao@nida.nih.gov.
amended, SACHRP was established to
provide expert advice and Jerry Menikoff, (Catalogue of Federal Domestic Assistance
Executive Secretary, Secretary’s Advisory Program Nos.: 93.279, Drug Abuse and
recommendations to the Secretary of Addiction Research Programs, National
Health and Human Services through the Committee on Human Research Protections,
Director, Office for Human Research Institutes of Health, HHS)
Assistant Secretary for Health on issues
Protections. Dated: June 16, 2015.
and topics pertaining to or associated
[FR Doc. 2015–15286 Filed 6–19–15; 8:45 am] Michelle Trout,
with the protection of human research
BILLING CODE 4150–36–P Program Analyst, Office of Federal Advisory
subjects.
The meeting will open to the public Committee Policy.
at 8:30 a.m. on Tuesday, July 21, 2015. [FR Doc. 2015–15168 Filed 6–19–15; 8:45 am]
DEPARTMENT OF HEALTH AND
Following opening remarks from Dr. BILLING CODE 4140–01–P
HUMAN SERVICES
Jerry Menikoff, Executive Secretary of
SACHRP and OHRP Director, and Dr. National Institutes of Health
Jeffrey Botkin, SACHRP Chair, the DEPARTMENT OF HEALTH AND
Subpart A Subcommittee (SAS) will National Institute on Drug Abuse; HUMAN SERVICES
present their report on informed consent Notice of Closed Meetings
for minimal risk research. SAS was National Institutes of Health
established by SACHRP in October 2006 Pursuant to section 10(d) of the
Federal Advisory Committee Act, as National Institute of Allergy and
and is charged with developing Infectious Diseases; Notice of Closed
recommendations for consideration by amended (5 U.S.C. App), notice is
hereby given of the following meetings. Meetings
SACHRP regarding the application of
The meetings will be closed to the
subpart A of 45 CFR part 46 in the Pursuant to section 10(d) of the
public in accordance with the
current research environment. Federal Advisory Committee Act, as
provisions set forth in sections
In the afternoon of July 21, the amended (5 U.S.C. App.), notice is
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Subcommittee on Harmonization (SOH) hereby given of the following meetings.
as amended. The grant applications and
will present their report, including
the discussions could disclose The meetings will be closed to the
recommendations pertaining to waiver
confidential trade secrets or commercial public in accordance with the
of consent in cluster randomized trials,
property such as patentable materials, provisions set forth in sections
the application of the HHS regulations
and personal information concerning 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
to data registries, and the topic of
individuals associated with the grant as amended. The grant applications and
‘‘benchmarking’’ in human subjects
applications, the disclosure of which the discussions could disclose
research. SOH was established by
would constitute a clearly unwarranted confidential trade secrets or commercial
SACHRP at its July 2009 meeting and is
invasion of personal privacy. property such as patentable material,
charged with identifying and
Name of Committee: National Institute on and personal information concerning
prioritizing areas in which regulations
Drug Abuse Special Emphasis Panel, individuals associated with the grant
and/or guidelines for human subjects
Developing Technologies and Tools to applications, the disclosure of which
research adopted by various agencies or Monitor HIV Brain Reservoirs and How They would constitute a clearly unwarranted
offices within HHS would benefit from May be Altered by Exposure to Substances of invasion of personal privacy.
harmonization, consistency, clarity, Abuse (R21/R33).
simplification and/or coordination. On Date: July 16, 2015. Name of Committee: National Institute of
July 22, the SOH will discuss the return Time: 1:30 p.m. to 3:30 p.m. Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
tkelley on DSK3SPTVN1PROD with NOTICES

of individual research results with Agenda: To review and evaluate grant
applications. Planning Grants (R34) and NIAID Clinical
special considerations regarding HIPAA Trial Implementation Cooperative Agreement
Place: National Institutes of Health,
and CLIA. Neuroscience Center, 6001 Executive (U01).
In the afternoon special guest speaker Boulevard, Rockville, MD 20852, (Telephone Date: July 17, 2015.
Dr. Robert Klitzman will present on his Conference Call). Time: 1:00 p.m. to 5:00 p.m.
recent work, The Ethics Police. The Contact Person: Susan O. McGuire, Ph.D., Agenda: To review and evaluate grant
meeting will adjourn at 4:30 p.m. on Scientific Review Officer, Office of applications.

VerDate Sep<11>2014 17:45 Jun 19, 2015 Jkt 235001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\22JNN1.SGM 22JNN1

Document Created: 2018-02-22 11:13:37
Document Modified: 2018-02-22 11:13:37

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 16, 2015.
FR Citation		80 FR 35656

80 FR 35656 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 119 (June 22, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health